Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Latest News

HIMS Stock Rises Overnight: Retail Traders Bet On Peptides Upside After FDA Panel Backs 6 Of 7 Compounds

Stocktwits • 07/27/2026

NIO Stock Rises Overnight: DRAM Bet On CXMT Pays Off As Chinese Chipmaker Soars Over 500% In Blockbuster IPO

Stocktwits • 07/27/2026

FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight

Benzinga • 07/25/2026

Hims & Hers (HIMS) Stock Looks Cheap On Cash Flow But Pricey After A 313% Run

Simply Wall St. • 07/24/2026

HIMS Stock Sinks as FDA Gives Hims & Hers Peptide the Cold Shoulder

Barchart • 07/24/2026